Related Experiment Video
Updated: Apr 11, 2026
12:45
Robot-assisted Total Mesorectal Excision and Lateral Pelvic Lymph Node Dissection for Locally Advanced Middle-low Rectal Cancer
Published on: February 12, 2022
7.0K
Robotically performed total mesorectal excision for rectal cancer
Chirurgia (Bucharest, Romania : 1990)
|May 27, 2015
Summary
Robotic surgery for rectal cancer, including total mesorectal excision (TME), is safe and effective. This approach offers oncological benefits and improved quality of life with low complication and recurrence rates.
Area of Science:
- Surgical Oncology
- Minimally Invasive Surgery
- Gastrointestinal Surgery
Background:
- Rectal cancer presents a significant health challenge, with increasing incidence.
- Surgical treatment for rectal cancer can impact patient quality of life.
Purpose of the Study:
- To evaluate the outcomes of robotic surgery for lower and middle rectal cancer.
- To assess the feasibility of robotic total mesorectal excision (TME).
Main Methods:
- Retrospective analysis of 117 rectal cancer patients treated with robotic surgery (2008-2012).
- Focus on patients undergoing robotic total mesorectal excision (TME).
Main Results:
- 79 patients (67.52%) underwent robotic TME.
- Low anterior resection was the most common procedure.
- Anastomotic fistula occurred in 11.39% and local recurrence in 2.53%.
Conclusions:
- Robot-assisted TME is feasible, safe, and associated with low complication and recurrence rates.
- Key benefits include oncological safety and enhanced quality of life.
- Robotic surgery shows potential to become the gold standard for rectal cancer treatment.
